3/1/2022Drug R&D and Product Registration News Digest February 2022 (3)

3/1/2022Digestome Therapeutics Licenses Schizophrenia Drug DGX-001 for Greater...

3/1/2022Heidelberg Pharma and Huadong Announce Strategic Partnership, Includin...

2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...

2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021

2/26/2022CARsgen Therapeutics Opens New U.S. cGMP Facility for CAR T Production

2/25/2022NMPA Announces Package Insert Revision of Proton Pump Inhibitor Drug F...

2/25/2022CDE Issues the Technical Guidelines for Clinical Trials of Human Fibri...

2/25/2022CDE Issues the Technical Guidance for Clinical Research of Human Rabie...

2/23/2022Lepu Biopharma Launches IPO on the Main Board of HKEX

2/23/202215 Category 4.1 Patent Invalidation Challenges Initiated in China afte...

2/23/2022OBI and Odeon Enter $200M License Deal for China Rights of OBI-999 a...

2/23/2022Kiniksa Pharma and Huadong Medicine Announce Strategic Collaboration

2/23/2022New Report: Assessment of China's Oncology Drugs Market 2022-2027

2/22/2022Luye Pharma and Biostar Agree to Co-market Anticancer Utidelone in Mai...

2/22/2022Kexing Biopharm to Pair with AntiV BioPharma to Jointly Develop Small-...

2/22/2022Stemirna gets ready for China's own mRNA Covid-19 vaccine as global mu...

2/22/2022CDE Seeks Comments on Draft Chinese Translation and Implementation Sug...

2/22/2022CDE Publicizes the Draft CDE Working Procedures for Accelerating Evalu...

2/22/2022Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...

2/22/2022State Council Issues New Plan on Senior Population Development and Eld...

2/21/2022245 Listed MedPharm Cos Release 2021 Performance Guidance and Results ...

2/21/2022Is China's Healthcare Industry the Next Regulatory Flashpoint under Bi...

2/21/2022Why Patient-Centric Innovation Holds the Key to Long-Term Business Suc...

2/21/2022Inter-Provincial Pacts on Bulk-Buying Drugs Are on the Rise in China, ...

2/21/2022Cross-border Medical Data Compliance in New Era of Regulation

2/21/2022Trends in China's Investigational New Drug Applications (PharmCube)

2/21/2022PharmaDJ's China NMPA Approval Tracker: JAK Inhibitors Take Center Sta...

2/18/2022CDE Issues the Technical Guidelines for Study on Mixing Uniformity and...

2/18/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guideline ICH E...

Page:164/790 Total number of articles:23693: [First][<<] [162] [163] [164] [165] [166] [>>] [End]